ERRATUM.

Text: In the article "Emergency department management of atrial fibrillation: 2023 consensus from the Spanish Society of Emergency Medicine (SEMES), the Spanish Society of Cardiology (SEC), and the Spanish Society of Thrombosis and Hemostasis (SETH)" published in Volume 35, Issue 5, October 2023, October 2023, there were some errors that are detailed and corrected below: On page 361, Figure 1, this originally published figure contained errors and would be replaced by the one attached below. On page 363, Table 1, in the column for rivaroxaban dose, where it says 20 mg/12 h, it should read 20 mg/24 h. On page 365, Figure 3, this originally published figure contained errors and would be replaced by the figure below.